Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 647 press releases before 2018
-
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
-
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
-
AstraZeneca provides update on Flumist Quadrivalent Vaccine in the US for the 2016-17 influenza season
-
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
-
AstraZeneca and Foundation Medicine enter strategic collaboration for Lynparza companion diagnostic assay
-
AstraZeneca completes US licensing agreement with Ironwood Pharmaceuticals for lesinurad
-
AstraZeneca licenses Zurampic to Grünenthal GmbH in Europe and Latin America
-
AstraZeneca’s Faslodex met primary endpoint in first-line treatment of advanced breast cancer
-
Positive CHMP opinion in EU for saxa/dapa (saxagliptin and dapagliflozin) for adults with type-2 diabetes
-
AstraZeneca receives Complete Response Letter from US FDA for sodium zirconium cyclosilicate (ZS-9) for oral suspension for treatment of hyperkalaemia
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Rob Skelding
Director Global Media Relations (Oncology)
+44 203 749 5821
Rebecca Einhorn
Director Global Media Relations (Oncology)
+1 301 398 1802
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
